Brokerages Set Transcat, Inc. (NASDAQ:TRNS) PT at $111.50

Shares of Transcat, Inc. (NASDAQ:TRNS) have earned an average recommendation of “Hold” from the five analysts that are covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $111.50.

A number of brokerages have weighed in on TRNS. StockNews.com lowered shares of Transcat from a “hold” rating to a “sell” rating in a research report on Wednesday, February 5th. Craig Hallum increased their target price on shares of Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th. Oppenheimer lowered shares of Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. HC Wainwright cut their target price on shares of Transcat from $126.00 to $106.00 and set a “buy” rating for the company in a research report on Wednesday, January 29th. Finally, Northland Securities reiterated a “market perform” rating and set a $85.00 target price (down previously from $110.00) on shares of Transcat in a research report on Wednesday, January 29th.

Transcat Stock Performance

NASDAQ TRNS opened at $82.80 on Friday. Transcat has a 52-week low of $73.37 and a 52-week high of $147.12. The company has a 50-day simple moving average of $95.03 and a 200 day simple moving average of $108.75. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.98 and a current ratio of 2.42. The company has a market capitalization of $770.79 million, a PE ratio of 44.76 and a beta of 0.68.

Transcat (NASDAQ:TRNS) last issued its earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.23%. During the same quarter last year, the firm earned $0.56 earnings per share. On average, research analysts predict that Transcat will post 2.3 EPS for the current year.

Insider Activity

In related news, Director Craig D. Cairns bought 1,200 shares of the stock in a transaction that occurred on Friday, January 31st. The shares were acquired at an average cost of $77.02 per share, with a total value of $92,424.00. Following the completion of the purchase, the director now directly owns 1,910 shares of the company’s stock, valued at $147,108.20. This trade represents a 169.01 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. 2.30% of the stock is owned by company insiders.

Institutional Investors Weigh In On Transcat

Institutional investors and hedge funds have recently bought and sold shares of the stock. Millrace Asset Group Inc. purchased a new stake in Transcat in the third quarter valued at approximately $655,000. Champlain Investment Partners LLC raised its stake in Transcat by 22.1% in the third quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company’s stock valued at $49,455,000 after purchasing an additional 74,169 shares in the last quarter. Conestoga Capital Advisors LLC raised its stake in Transcat by 17.9% in the third quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock valued at $109,561,000 after purchasing an additional 137,830 shares in the last quarter. State Street Corp raised its stake in Transcat by 8.1% in the third quarter. State Street Corp now owns 207,230 shares of the scientific and technical instruments company’s stock valued at $25,027,000 after purchasing an additional 15,514 shares in the last quarter. Finally, Geode Capital Management LLC raised its stake in Transcat by 5.4% in the third quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company’s stock valued at $26,269,000 after purchasing an additional 11,106 shares in the last quarter. 98.34% of the stock is owned by hedge funds and other institutional investors.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.